NCT00274716View on ClinicalTrials.gov

Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED)

PHASE2CompletedINTERVENTIONAL

Enrollment

249

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Hypertension

Interventions

DRUG

MK0736

DRUG

MK0916

DRUG

Placebo

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00274716 - Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED) | Biotech Hunter | Biotech Hunter